These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21049090)

  • 81. Drug Formulation Impact on Prefilled Syringe Functionality and Autoinjector Performance.
    Fang L; Shi GH; Richard CA; Dong X; Thomas JC; Victor MC; Wang T; Shinkle S; Zhao C
    PDA J Pharm Sci Technol; 2020; 74(6):674-687. PubMed ID: 32817321
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis.
    Mikol D; Lopez-Bresnahan M; Taraskiewicz S; Chang P; Rangnow J;
    Mult Scler; 2005 Oct; 11(5):585-91. PubMed ID: 16193898
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A study on the safety evaluation of buphrenorphine administered through an autoinjector compared with manual injection using haematological and biochemical variables in rats.
    Sheela D; Vijayaraghavan R; Senthilkumar S
    Hum Exp Toxicol; 2017 Sep; 36(9):901-909. PubMed ID: 28838259
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors.
    Barone DA; Singer BA; Merkov L; Rametta M; Suarez G
    Neurol Ther; 2016 Dec; 5(2):155-167. PubMed ID: 27277705
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Tissue Resistance during Large-Volume Injections in Subcutaneous Tissue of Minipigs.
    Allmendinger A; Fischer S
    Pharm Res; 2020 Sep; 37(10):184. PubMed ID: 32888065
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis.
    Singer B; Wray S; Miller T; Cascione M; Gupta A; Pardo G; Watsky E; Hayward B; Mercer B; Dangond F
    Mult Scler Relat Disord; 2012 Apr; 1(2):87-94. PubMed ID: 25876936
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth.
    Travanty MN; Calawa B; Shalaby WS; Jozwiakowski MJ; Haraldsen KB
    Med Devices (Auckl); 2018; 11():241-252. PubMed ID: 30100767
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Self-administration with UniJect of the once-a-month injectable contraceptive Cyclofem.
    Bahamondes L; Marchi NM; Nakagava HM; de Melo ML; Cristofoletti Mde L; Pellini E; Scozzafave RH; Petta C
    Contraception; 1997 Nov; 56(5):301-4. PubMed ID: 9437558
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Comparison of pharmacokinetics and safety of pegfilgrastim administered by two delivery methods: on-body injector and manual injection with a prefilled syringe.
    Yang BB; Morrow PK; Wu X; Moxness M; Padhi D
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1199-206. PubMed ID: 25894719
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The thigh may not be suitable as an injection site for patients self-injecting sumatriptan.
    Frid A; Hardebo JE
    Neurology; 1997 Aug; 49(2):559-61. PubMed ID: 9270596
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.
    Kivitz A; Olech E; Borofsky MA; Zazueta B; Navarro-Sarabia F; Radominski SC; Merrill JT; Pacheco-Tena C; Pei J; Nasmyth-Miller C; Pope JE
    J Rheumatol; 2018 Apr; 45(4):456-464. PubMed ID: 29247149
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
    Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
    Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart
    Krol M; de Voer G; Osowski U
    Patient Prefer Adherence; 2017; 11():1189-1196. PubMed ID: 28744108
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon(R)) by Pen-injector and syringe.
    Voortman G; van de Post J; Schoemaker RC; van Gerven JM
    Hum Reprod; 1999 Jul; 14(7):1698-702. PubMed ID: 10402370
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Formative and Validation Human Factors studies of a new disposable autoinjector for subcutaneous delivery of chronic disease therapies.
    Lageat C; Combedazou A; Ramus C; Guerrero K; Frolet C; Glezer S
    Expert Opin Drug Deliv; 2021 Nov; 18(11):1761-1775. PubMed ID: 34448423
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Are adrenaline autoinjectors fit for purpose? A pilot study of the mechanical and injection performance characteristics of a cartridge-versus a syringe-based autoinjector.
    Schwirtz A; Seeger H
    J Asthma Allergy; 2010 Nov; 3():159-67. PubMed ID: 21437050
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Safety evaluation of antibacterial and analgesic autoinjector devices for rapid administration during emergency situations: a crossover study in rabbits.
    Vijayaraghavan R; Senthilkumar S; Roy A; Sheela D; Geetha RV; Magesh A
    SAGE Open Med; 2022; 10():20503121221108614. PubMed ID: 35832261
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Towards more tolerable subcutaneous administration: Review of contributing factors for improving combination product design.
    Mathias N; Huille S; Picci M; Mahoney RP; Pettis RJ; Case B; Helk B; Kang D; Shah R; Ma J; Bhattacharya D; Krishnamachari Y; Doucet D; Maksimovikj N; Babaee S; Garidel P; Esfandiary R; Gandhi R
    Adv Drug Deliv Rev; 2024 Jun; 209():115301. PubMed ID: 38570141
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Optimizing autoinjector devices using physics-based simulations and Gaussian processes.
    Sree V; Zhong X; Bilionis I; Ardekani A; Tepole AB
    J Mech Behav Biomed Mater; 2023 Apr; 140():105695. PubMed ID: 36739826
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions.
    Schneider A; Jost R; Jordi C; Lange J
    Expert Opin Drug Deliv; 2023 Jun; 20(6):815-830. PubMed ID: 37272119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.